$1.750
+0.239 (+13.64%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CVKD Prediction & Forecast by Similar Chart Analysis
Alphio's CVKD stock price prediction model matches the current Cadrenal Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.52 (+0.68%). The 1-week path is $1.56 (+3.63%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Cadrenal Therapeutics Inc Stock?
Cadrenal Therapeutics Inc (CVKD) is currently not a good buy due to its low price of $1.54, which is significantly down 78.99% year-to-date, indicating substantial market skepticism. The RSI is at 23.316, suggesting the stock is oversold, but this could also indicate continued weakness. The forward P/E ratio is 0, reflecting uncertainty in future earnings, and the company has reported consistent net losses, with the latest quarterly net income at -2,496,540 USD.
CVKD stock price ended at $1.75 on Monday, after rising +13.64%
Cadrenal Therapeutics Inc (CVKD) last closed at $1.51, losing -13.71%. These facts feed the 1-day and 1-week CVKD price prediction above.
Forecast Drivers
Cadrenal Therapeutics Inc (CVKD) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CVKD, ranked by similarity.
Seasonality analysis for CVKD
Historically the probability of a positive September return for CVKD is 30.95%. January offers the highest probability of a positive month at 75.41%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CVKD
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $9.86 | $10.76 | $11.67 | +612.80% |
| Oct 2026 | $9.40 | $10.80 | $11.54 | +615.47% |
| Nov 2026 | $8.95 | $10.19 | $10.29 | +574.74% |
| Dec 2026 | $11.65 | $12.26 | $12.79 | +711.95% |
In 2026, Cadrenal Therapeutics Inc (CVKD) is projected to range from $8.95 to $12.79.
Cadrenal Therapeutics Inc 2026 monthly forecast
In Sep 2026, Cadrenal Therapeutics Inc is projected to average $10.76, with a low of $9.86 and high of $11.67.
In Oct 2026, Cadrenal Therapeutics Inc is projected to average $10.80, with a low of $9.40 and high of $11.54.
In Nov 2026, Cadrenal Therapeutics Inc is projected to average $10.19, with a low of $8.95 and high of $10.29.
In Dec 2026, Cadrenal Therapeutics Inc is projected to average $12.26, with a low of $11.65 and high of $12.79.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.